Patient Asks Why Drug Companies Are "Trying To Prevent Disclosure Of Trial Data"
A personal view from a patient with a potentially life-limiting illness published this week on bmj.com asks why pharmaceutical giants are trying to prevent the disclosure of trial data. Since he started taking adalimumab for his Crohn's disease three years ago, he says he has rarely felt better: he is no longer taking steroids, has started to recover from 15 years of side effects and spends less time in care and off work on sick leave...
More...
A personal view from a patient with a potentially life-limiting illness published this week on bmj.com asks why pharmaceutical giants are trying to prevent the disclosure of trial data. Since he started taking adalimumab for his Crohn's disease three years ago, he says he has rarely felt better: he is no longer taking steroids, has started to recover from 15 years of side effects and spends less time in care and off work on sick leave...
More...